ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $147,287 (100.0% shares, 0.0% debt)

Holdings (30)

New Positions (7)

NERV MINERVA NEUROSCIENCES 1.9%
Value ($000) $2,852 Shares 709,500 Est. Cost $3.71 Unrealized 0.0%
TNGX TANGO THERAPEUTICS INC 1.7%
Value ($000) $2,505 Shares 282,732 Est. Cost $8.62 Unrealized 0.0%
DSGN DESIGN THERAPEUTICS INC 1.0%
Value ($000) $1,415 Shares 150,906 Est. Cost $7.83 Unrealized 0.0%
MAZE MAZE THERAPEUTICS INC 0.6%
Value ($000) $829 Shares 20,000 Est. Cost $34.37 Unrealized 0.0%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.5%
Value ($000) $781 Shares 59,280 Est. Cost $11.80 Unrealized 0.0%
STRO SUTRO BIOPHARMA INC 0.5%
Value ($000) $780 Shares 67,451 Est. Cost $9.49 Unrealized 0.0%
KTTA PASITHEA THERAPEUTICS CORP 0.4%
Value ($000) $581 Shares 450,000 Est. Cost $0.88 Unrealized 0.0%

Increased Positions (4)

TERN TERNS PHARMACEUTICALS INC 17.5%
Value ($000) $25,739 (+581.6%) Shares 637,095 (+26.7%) Est. Cost $9.17 Unrealized +152.0%
PRAX PRAXIS PRECISION MEDICINES I 16.6%
Value ($000) $24,474 (+828.2%) Shares 83,036 (+66.9%) Est. Cost $95.33 Unrealized +95.4%
CMPX COMPASS THERAPEUTICS INC 4.0%
Value ($000) $5,871 (+99.7%) Shares 1,093,300 (+30.1%) Est. Cost $3.50 Unrealized +32.1%
JAZZ JAZZ PHARMACEUTICALS PLC 3.3%
Value ($000) $4,931 (+49.0%) Shares 29,008 (+15.5%) Est. Cost $121.51 Unrealized +26.2%

Exited Positions (5)

— TOURMALINE BIO INC 8.7%
Value ($000) $12,840 Shares 268,451 Est. Cost $23.42 Unrealized —
ASND ASCENDIS PHA-ADR 1.3%
Value ($000) $1,947 Shares 9,792 Est. Cost $148.43 Unrealized —
KRYS KRYSTAL BIOTECH INC 1.3%
Value ($000) $1,866 Shares 10,573 Est. Cost $149.68 Unrealized +40.6%
COGT COGENT BIOSCIENCES INC 1.0%
Value ($000) $1,478 Shares 102,907 Est. Cost $11.85 Unrealized +137.3%
FULC FULCRUM THERAPEUTICS INC 0.4%
Value ($000) $526 Shares 57,141 Est. Cost $5.35 Unrealized +90.3%

Decreased Positions (5)

— CIDARA THERAPEUTICS INC 13.4%
Value ($000) $19,691 (+45.3%) Shares 89,145 (-37.0%) Est. Cost $31.31 Unrealized —
INSM INSMED INC 3.1%
Value ($000) $4,504 (-19.0%) Shares 25,878 (-32.9%) Est. Cost $47.04 Unrealized +287.9%
OCUL OCULAR THERAPEUTIX INC 8.7%
Value ($000) $12,783 (-6.2%) Shares 1,052,995 (-9.6%) Est. Cost $6.18 Unrealized +96.5%
ARGX ARGEN SE - ADR 2.8%
Value ($000) $4,079 (-13.3%) Shares 4,851 (-24.0%) Est. Cost $489.55 Unrealized —
DNTH DIANTHUS THERAPEUTICS INC 0.5%
Value ($000) $689 (-30.0%) Shares 16,708 (-33.2%) Est. Cost $25.56 Unrealized +51.7%

Unchanged Positions (14)

WHWK WHITEHAWK THERAPEUTICS INC 5.6%
Value ($000) $8,253 Shares 3,410,402 Est. Cost $16.10 Unrealized -85.7%
SRZN SURROZEN INC 2.7%
Value ($000) $4,032 Shares 178,415 Est. Cost $11.57 Unrealized +39.8%
DRUG BRIGHT MINDS BIOSCIENCES INC 4.5%
Value ($000) $6,593 Shares 84,477 Est. Cost $36.75 Unrealized +81.9%
TSHA TAYSHA GENE THERAPIES INC 1.7%
Value ($000) $2,502 Shares 454,827 Est. Cost $2.17 Unrealized +123.5%
INBX INHIBRX BIOSCIENCES INC 0.9%
Value ($000) $1,294 Shares 16,377 Est. Cost $24.62 Unrealized +176.8%
ZYME ZYMEWORKS INC 1.4%
Value ($000) $2,110 Shares 80,143 Est. Cost $13.60 Unrealized +60.4%
AMLX AMYLYX PHARMACEUTICALS INC 2.7%
Value ($000) $4,026 Shares 333,258 Est. Cost $9.41 Unrealized +44.3%
RVMD REVOLUTION MEDICINES INC 0.5%
Value ($000) $670 Shares 8,411 Est. Cost $24.90 Unrealized +163.3%
OCS OCULIS HOLDING AG 1.4%
Value ($000) $2,032 Shares 101,777 Est. Cost $20.50 Unrealized -2.4%
LBRX LB PHARMACEUTICALS INC 0.5%
Value ($000) $668 Shares 30,000 Est. Cost $15.87 Unrealized +10.1%
VSTM VERASTEM INC 0.8%
Value ($000) $1,107 Shares 143,446 Est. Cost $6.11 Unrealized +45.9%
UTHR UNITED THERAPEUTICS CORP 0.8%
Value ($000) $1,119 Shares 2,296 Est. Cost $336.31 Unrealized +38.5%
UNCY UNICYCIVE THERAPEUTICS INC 0.2%
Value ($000) $346 Shares 59,985 Est. Cost $6.18 Unrealized -13.7%
— NUVATION BIO INC -CW27 0.0%
Value ($000) $30 Shares 90,832 Est. Cost $0.28 Unrealized —